• Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016
Monday Morning
Skip to content
  • Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016

Tag Archives: Paul Sperber

Bristol Myers Clobbered as Cancer Drug Disappoints; Rival Merck Unanimous Winner at Medical Conference

Steve Walker    October 14, 2016 May 7, 2018    No Comments on Bristol Myers Clobbered as Cancer Drug Disappoints; Rival Merck Unanimous Winner at Medical Conference

New data are likely to prompt doctors to abandon Bristol-Myers Squibb Co.’s (New York City) immunotherapy Opdivo in favor of Merck & Co.’s (Kenilworth NJ) rival Keytruda in a large… Read more »

Corporate, Disease, Pharmaceuticals    AstraZeneca PLC, Bristol-Myers Squibb Co., Chris Schott, European Society for Medical Oncology, Evercore ISI, Fortunato Ciardiello, J.P. Morgan, Keytruda, Leerink Partners LLC, MarketWatch, Merck & Co., Opdivo, Paul Sperber, Pfizer Inc., Roche Holding AG, Roger Perlmutter, Sanford C. Bernstein, Seamus Fernandez, Tecentriq, Tim Anderson

Search The Site

Follow @MonMorningNews

Twitter

Tweets by MonMorningNews
Follow me on Blogarama

Facebook

Search The Site

More MondayMorning

  • Recent Posts
  • Most Commented
  • Most Viewed
  • Reducing salt consumption may protect against Alzheimer’s. Considering the stakes, start now.
  • US stock market has a subdued Thanksgiving week, but a slew of healthcare companies rocketed higher.
  • More Chinese medical companies choosing New York over Shanghai, Hong Kong for IPOs; but not always.
  • Health-sector IPO market cools off for Veterans Day breather; but pre-Thanksgiving deals ready to rock.
    • Insys trial opens with tale of sales rep giving lap dance to doctor for fentanyl prescriptions. News organizations seize upon...
    • Voyager Therapeutics signs another neurodegenerative disease deal with AbbVie that screams “Buy this small cap now.”
    • Little known Czech biotech’s cell therapy greatly increases survival in ovarian cancer. Sotio’s potential breakthrough and another pipeline cancer candidate...
    • Powered only by heart muscle, experimental pacemaker doesn’t need new batteries. Goodbye (hopefully) to battery-replacement surgery; but hello international patent...
    Copyright 2018
    Ribosome by GalussoThemes.com
    Powered by WordPress